Alternatives to Breeze Meds

A tiered compounded program that lays every price on the table — semaglutide, tirzepatide, a microdose lane, and a combo option — with six-month metabolic lab testing and an NAD+ adjacency that speaks to women thinking about metabolism as a whole system.

One of the lowest compounded-tirzepatide entry points we log — from $179, or $149 for a microdose — paired with a rare all-50-states footprint and an optional brand path. The adjacent HRT and menopause line is a genuine draw for women managing metabolism and hormones together.

Both molecules at prices you can see up front, wrapped in a wider menu — NAD+, microdosing, and an optional coaching-and-labs bundle — for a woman who wants weight care and energy alongside it.

An established national telehealth marketplace with the widest real brand-name GLP-1 access on the board — Wegovy (pen and pill), Zepbound, Ozempic and Mounjaro — plus provider-by-provider price transparency.

A LegitScript-certified, physician-supervised program with a rare oral GLP-1 tablet alongside injections — both molecules, transparent no-insurance pricing, and an accreditation signal that reassures when hormones are in play.

One of the few programs with a women's weight-loss line of its own, and the widest set of routes we track — injectable or sublingual, semaglutide or tirzepatide, each with its price on the page.

A LegitScript-verified compounded program that charges one flat price at every dose — so titrating up to a working dose never quietly raises the bill.

Among the lowest verified prices we log — compounded semaglutide and tirzepatide on a single membership, shipped nationwide. A budget-first on-ramp for women who want tirzepatide access without paying a premium.

A high-transparency program with unusually clear clinician and supply-chain disclosure — you can see who is prescribing and where the medication comes from, which is rarer than it should be.